ロード中...
VE1 immunohistochemistry is an adjunct tool for detection of BRAF (V600E) mutation: Validation in thyroid cancer patients
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy among other endocrine tumors, and BRAF (V600E) is a frequent genetic mutation occurring in the disease. Although different molecular techniques, most importantly sequencing has been widely recognized as a gold standard but mol...
保存先:
| 出版年: | J Clin Lab Anal |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7891529/ https://ncbi.nlm.nih.gov/pubmed/33305405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.23628 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|